Comparing Hemo to the clinical !!!! So undervalued12 Feb 2024 09:35
For all those newbies and people who are seeing red on HEMO today, here is some datapoints that should help make a decision in buying hemo at this stupidly low and manipulated prices !!!
- If you could buy a clinically and FDA approved pharma company for less than $45m mcap anywhere in the world, buy it since that is what HEMO currently is. There is again limited coverage and no marketing and it is so under the radar
- As JHFH has stated many times, the lowest company with equivalent approvals is anywhere above $100m so that is a 60% discount at a bare minimum to hemo
- That does not include any value on CBR or CDX which we will now get real updates and progress since hemo can look for investment and focus on this as well.
- We have seen hemo move from 1.2p to 4.8p in jan 2022 and from 2p to over 4.5p a few months ago. This is a highly manipulated stock and not for the impatient like I was for many years. Thanks for support from JHFH and others and brilliant scientific updates from Haywain, I kept averaging down and now am positive.
LAST POINT. WE ARE NOT THE FINAL STAGE OF HEMO'S LIFE BUT THE START. Upto now we have all faced pain and delay and regret with hemo but for those that are looking at a new investment, this is crazy low. It went to nearly 7p on friday before traders destroyed the rise. THIS IS PROBABLY THE BEST SMALL STOCK INVESTMENT OUT THERE AND THE RISK REWARD RATIO IS NOW FIRMALY TOWARDS A REWARD !!! DYOR